1. Home
  2. RCEL vs FTLF Comparison

RCEL vs FTLF Comparison

Compare RCEL & FTLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • FTLF
  • Stock Information
  • Founded
  • RCEL N/A
  • FTLF 2005
  • Country
  • RCEL United States
  • FTLF United States
  • Employees
  • RCEL N/A
  • FTLF N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • FTLF Medicinal Chemicals and Botanical Products
  • Sector
  • RCEL Health Care
  • FTLF Health Care
  • Exchange
  • RCEL Nasdaq
  • FTLF Nasdaq
  • Market Cap
  • RCEL 140.5M
  • FTLF 149.3M
  • IPO Year
  • RCEL N/A
  • FTLF N/A
  • Fundamental
  • Price
  • RCEL $5.33
  • FTLF $20.03
  • Analyst Decision
  • RCEL Strong Buy
  • FTLF Strong Buy
  • Analyst Count
  • RCEL 4
  • FTLF 2
  • Target Price
  • RCEL $13.75
  • FTLF $23.00
  • AVG Volume (30 Days)
  • RCEL 267.6K
  • FTLF 15.8K
  • Earning Date
  • RCEL 11-06-2025
  • FTLF 11-13-2025
  • Dividend Yield
  • RCEL N/A
  • FTLF N/A
  • EPS Growth
  • RCEL N/A
  • FTLF N/A
  • EPS
  • RCEL N/A
  • FTLF 0.80
  • Revenue
  • RCEL $74,884,000.00
  • FTLF $63,053,000.00
  • Revenue This Year
  • RCEL $22.92
  • FTLF $34.34
  • Revenue Next Year
  • RCEL $37.07
  • FTLF $48.58
  • P/E Ratio
  • RCEL N/A
  • FTLF $25.03
  • Revenue Growth
  • RCEL 38.32
  • FTLF 3.91
  • 52 Week Low
  • RCEL $3.60
  • FTLF $9.83
  • 52 Week High
  • RCEL $14.16
  • FTLF $20.98
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 49.55
  • FTLF 57.48
  • Support Level
  • RCEL $5.14
  • FTLF $19.76
  • Resistance Level
  • RCEL $5.61
  • FTLF $20.77
  • Average True Range (ATR)
  • RCEL 0.24
  • FTLF 0.48
  • MACD
  • RCEL -0.03
  • FTLF -0.11
  • Stochastic Oscillator
  • RCEL 41.94
  • FTLF 25.35

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About FTLF FitLife Brands Inc.

FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.

Share on Social Networks: